English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1876]
News [4318]
Articles [406]
Editorials [10]
Conferences [107]
elearning [41]
AI-based breast cancer risk technology receives FDA Breakthrough Device designation
AI-based breast cancer risk technology receives FDA Breakthrough Device designation
Binding affinity and structural dynamics of amygdalin-HER2 interactions: An investigation for breast cancer therapy
Binding affinity and structural dynamics of amygdalin-HER2 interactions: An investigation for breast cancer therapy
Respiratory infections may increase breast cancer lung metastases (N&V)
Respiratory infections may increase breast cancer lung metastases (N&V)
When should preventive mastectomy be offered for women at higher risk of breast cancer
When should preventive mastectomy be offered for women at higher risk of breast cancer
Oxidative stress may suppress cancer onset in individuals with BRCA2 gene variants
Oxidative stress may suppress cancer onset in individuals with BRCA2 gene variants
New methods show how fast breast cancers grow and how surgery delays affect cancer staging
New methods show how fast breast cancers grow and how surgery delays affect cancer staging
Women of African ancestry may be biologically predisposed to early onset or aggressive breast cancers
Women of African ancestry may be biologically predisposed to early onset or aggressive breast cancers
Beyond the mammogram: Study finds differences between benign and cancerous breast calcifications
Beyond the mammogram: Study finds differences between benign and cancerous breast calcifications
Powerlifting through breast cancer – how a breast cancer survivor defied chemotherapy with strength training
Powerlifting through breast cancer – how a breast cancer survivor defied chemotherapy with strength training
NICE recommends ribociclib for eligible HR+/HER2- early breast cancer patients at high risk of recurrence
NICE recommends ribociclib for eligible HR+/HER2- early breast cancer patients at high risk of recurrence
<12345...432>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top